Tender detail

Amgros medicines framework agreements 2027

Summary

Amgros is procuring medicines for Danish hospital pharmacies under 10 separate lots, covering infliximab, adalimumab and ustekinumab in specified strengths and infusion or injection forms. The estimated total value is DKK 1,266,300,000, with a maximum value of DKK 1,646,190,000. The framework agreements are non-exclusive and do not guarantee purchases; actual demand may differ substantially from historical consumption.

Reference number
Buyer
Amgros I/S
Country
Denmark (DNK)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2027-01-14
Status
Open
Contract subject
Supplies
Estimated value
1 266 300 000,00 DKK
Source
DNK_UDBUD

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.